FSDDF - Auxly Terminates JV Deal With FSD Pharma: Who To Believe?
Earlier this month, Auxly (CBWTF) and FSD Pharma (FSDDF) announced the termination of a joint-venture agreement between the two parties. As a result, Auxly lost an important future supplier and likely wasted valuable time and resources while FSD will face an upcoming funding shortfall and potentially significantly delayed timeline. The two companies individually issued loaded press releases alleging each other as the cause for the termination. We will focus on and discuss the implications for Auxly and why this event confirmed the riskiness of its business model.
The Drama Begins
On